<b>Harvard Pilgrim</b> Signs Outcomes-Based Contracts With AstraZeneca PLC For Brilinta And Bydureon Post author:Sam Post published:May 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017 Kindred Bio To Announce Second Quarter 2017 Financial Results July 23, 2017 As Its R&D Boss 'Retires,' Eli Lilly CEO Taps an Entirely New C-Suite for 2018 September 28, 2017
NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017